Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

14.65
+0.92006.70%
Volume:223.50K
Turnover:3.27M
Market Cap:37.32M
PE:- -
High:14.80
Open:14.34
Low:14.34
Close:13.73
52wk High:36.00
52wk Low:9.23
Shares:2.55M
Float Shares:2.55M
Volume Ratio:2.71
T/O Rate:8.77%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo Nordisk Q2 Lifts FY Guidance on Stronger GLP-1 Demand

Reuters
·
Aug 05

Novo Nordisk Boosts Adjusted Sales, Operating Profit Guidance for 2026

MT Newswires Live
·
Aug 05

Novo Nordisk reports Q2 adjusted sales DKK 78.49B, up 7% at CER

TIPRANKS
·
Aug 05

Novo Nordisk raises FY26 adjusted sales view to 0% to down 6% from down 4%-12%

TIPRANKS
·
Aug 05

Novo Nordisk Probes Thyroid Cancer Risk in Real‑World GLP‑1 Users

TIPRANKS
·
Aug 05

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Aug 04

Legal Inquiry Launched for Hims & Hers Health Following Share Plunge

Deep News
·
Aug 04

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 04

Novo Nordisk Earnings Seen Lower; Guidance and Wegovy Pill in Focus

Dow Jones
·
Aug 03

Stock Markets Can't Rely on Tech to Power Gains Anymore

Dow Jones
·
Aug 03

Novo Nordisk A/S Expected to Post Earnings of Dkk4.99 a Share - Earnings Preview

Reuters
·
Aug 03

Novo Nordisk (NYSE:NVO) Ziltivekimab Trial Fails In Late Stage Cardiovascular Study

Simply Wall St.
·
Aug 02

Is Novo Nordisk Stock (NVO) a Good Buy After Today’s Plunge?

TIPRANKS
·
Aug 01

Exchange Traded Funds Top 10 Percentage Losers

Dow Jones
·
Aug 01

Nasdaq Composite Index Rises 1% as Amazon Surges 15% After Results; Apple and Micron Fall as Memory Stocks Retreat

TradingKey
·
Aug 01

Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback

TIPRANKS
·
Aug 01

European Stocks Wipe Out Monthly Gains as Novo Nordisk and Universal Music Plunge

Deep News
·
Aug 01

Canada Net Change Percentage Gainers & Losers

Dow Jones
·
Aug 01

Novo Nordisk A/S Stock (NVO) Moved Down by 8.75% on Jul 31: Key Drivers Unveiled

TradingKey
·
Aug 01

European Equities Mixed in Friday Trading; Novo Nordisk Says Ziltivekimab Fails to Reduce Major Adverse Cardiovascular Events in Trial

MT Newswires Live
·
Aug 01